PATIENT PREFERENCES AND RANDOMIZED CLINICAL-TRIALS
PATIENT PREFERENCES AND RANDOMIZED CLINICAL-TRIALS
复制标题
DOI:
10.1136/bmj.299.6694.313
复制
发表时间:
1989-07-29
影响因子:
--
通讯作者:
BRADLEY, C
中科院分区:
文献类型:
--
作者:
BREWIN, CR;BRADLEY, C
Allocating patients to different treatments by randomisation in a controlled trial is now accepted almost without question in accounts of trial design.'Randomisation may reasonably be supposed to play a large part in evaluating proposed studies for grant support. The virtue of randomisation is that it reduces some types of systematic error that may interfere with the interpretation of the results of a trial. Allocating patients to treatments in a systematic non-randomised way may introduce bias which destroys comparability. We argue here that despite this advantage random allocation is not always suitable. Though patients play an active part in the outcome of all treatments, we suggest that clinical trials in which they are required to sustain an effortful and demanding role and those in which they are likely to have strong preferences for one treatment need to be considered and conducted differently.Motivation Patients' motivation to follow treatment regimens is likely to be influenced by any preference before treatment is begun for one particular course of action. The greater the need for participation the greater is the scope for motivation to influence outcome. Such" participative" interventions include self monitoring, diet, ar4d self medication regimens for patients with diabetes; rehabilitation programmes for patients recovering from a myocardial infarction; counselling for patients with cancer or those at high risk of passing disorders to their offspring; behavioural and